Mukka Proteins Limited — QIP/Rights/Pref., 21-10-2024: Preferential issue

Mukka Proteins Limited's Board of Directors approved an increase in authorized share capital from ₹30 crores to ₹40 crores, subject to shareholder approval. Additionally, the company plans to issue up to 1,96,00,000 equity shares at ₹50 each, totaling ₹98 crores, on a preferential basis. An Extra-Ordinary General Meeting will be held to discuss these resolutions. Detailed information will be provided in the notice of the meeting shortly.